Estimation of Duration of Symptoms in Fulminant Type 1 Diabetes Mellitus Using HbA(1c) or Glycated Albumin

被引：1
|
作者：
Kawabe, Akitsu [1 ]
Seta, Takashi [1 ]
Fujii, Sumie [1 ]
Yamada, Masayo [2 ]
Oki, Shogo [3 ]
Murai, Jun [4 ]
Saito, Hiroshi [4 ]
Koga, Masafumi [4 ]
机构：
[1] Ishikawa Prefectural Cent Hosp, Dept Internal Med, Kanazawa, Ishikawa 9268530, Japan
[2] Yokohama Sakae Kyosai Hosp, Dept Internal Med, Yokohama, Kanagawa 2478581, Japan
[3] Osaka Red Cross Hosp, Dept Diabet & Endocrinol, Osaka 5438555, Japan
[4] Kinki Cent Hosp, Dept Internal Med, 3-1 Kuruma Zuka, Itami, Hyogo 6648533, Japan
来源：
JAPANESE CLINICAL MEDICINE | 2012年 / 3卷
关键词：
HbA(1c); glycated albumin; fulminant type 1 diabetes mellitus;
D O I：
10.4137/JCM.S9509
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Fulminant type 1 diabetes mellitus (FT1DM) develops as a result of very rapid and almost complete destruction of pancreatic beta cells. Because of an abrupt increase in plasma glucose, HbA(1c) and glycated albumin (GA) might increase along with duration of symptoms in FT1DM patients. We attempted to devise a formula to estimate duration of symptoms based on the increased levels in HbA(1c) or GA. Four patients who developed FT1DM during the course of type 2 diabetes mellitus and in whom HbA(1c) was measured before onset were investigated in this study. The percents of the estimated duration of symptoms calculated from HbA(1c) (four patients) and GA (two patients) to the actual duration were 137 +/- 88% and 122%, respectively. In FT1DM patients in whom HbA(1c) and/or GA before onset and at the time of ketoacidosis are measured, duration of symptoms might be estimated with using the increased levels in HbA(1c) or GA.
引用
收藏
页码：15 / 20
页数：6
相关论文
共 50 条
  • [31] Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1c
    Shunsuke Kato
    Izumi Otaka
    Hanako Toyama
    Ryota Kusumi
    Kazuyuki Takahashi
    Mitsuhiko Nara
    Yumi Suganuma
    Takehiro Sato
    Tsukasa Morii
    Hiroki Fujita
    Hironori Waki
    Diabetology International, 2022, 13 : 698 - 703
  • [32] Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1c
    Kato, Shunsuke
    Otaka, Izumi
    Toyama, Hanako
    Kusumi, Ryota
    Takahashi, Kazuyuki
    Nara, Mitsuhiko
    Suganuma, Yumi
    Sato, Takehiro
    Morii, Tsukasa
    Fujita, Hiroki
    Waki, Hironori
    DIABETOLOGY INTERNATIONAL, 2022, 13 (04) : 698 - 703
  • [33] Fulminant type 1 diabetes mellitus
    You, Wei
    Yang, Jianming
    Liu, Yanqun
    Wang, Wen
    Zhu, Li
    Wang, Wei
    Yang, Jun
    Chen, Fangyuan
    MEDICINE, 2019, 98 (05)
  • [34] Fulminant type 1 diabetes mellitus
    Imagawa, Akihisa
    Hanafusa, Toshiaki
    ENDOCRINE JOURNAL, 2006, 53 (05) : 577 - 584
  • [35] Glycated albumin levels are higher relative to HbA1c levels in people with autoimmune acute-onset type 1 diabetes mellitus than in people with type 2 diabetes mellitus at the time of diagnosis
    Koga, Masafumi
    Murai, Jun
    Saito, Hiroshi
    Aoki, Keiko
    Kanehara, Hideo
    Bando, Yukihiro
    Morita, Shinya
    Kasayma, Soji
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (01) : E12 - E14
  • [36] American Diabetes Association proposes to use HbA(1c) level for diagnosis of diabetes mellitus
    Sukhareva, O. Yu.
    DIABETES MELLITUS, 2009, 12 (04): : 126 - 126
  • [37] Diagnostic performance of glycated haemoglobin (HbA1c) for diabetes mellitus in dogs
    Oikonomidis, I. L.
    Tsouloufi, T. K.
    Tzenetidou, Z.
    Ceron, J. J.
    Tvarijonaviciute, A.
    Konstantinidis, A. O.
    Soubasis, N.
    VETERINARY JOURNAL, 2023, 294
  • [38] Request adequacy of glycated hemoglobin (HbA1C) in the management of diabetes mellitus
    Delgado Rodriguez, J. A.
    Morell Garcia, D.
    Ramos Chavarino, D.
    Tarazona Pastor, A. C.
    Llompart Alabern, I.
    Bauca Rossello, J. M.
    CLINICA CHIMICA ACTA, 2019, 493 : S298 - S298
  • [39] Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients
    Wang, Dong-Dong
    Zhang, Cun
    Hu, Ke
    He, Su-Mei
    Zhu, Ping
    Chen, Xiao
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [40] HbA1c level in type 2 diabetes mellitus patients with depressive symptoms
    Apriansyah, M. A.
    Kartika, H.
    Putranto, R.
    Shatri, H.
    Mudjaddid, E.
    Kusnadi, Y.
    Shahab, A.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2013, 82 : 6 - 6
12345